Prana recruiting for Alzheimer's drug trial

12/15/2011 | MarketWire

Prana Biotechnology said it has started screening patient participants for a Phase II imaging trial of its experimental Alzheimer's disease drug PBT2. The trial will use PiB-PET imaging and blood tests to determine the effects of the drug.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT